Procurement Summary
Country: Norway
Summary: Development Services for Minimally Invasive Glaucoma Surgery (Migs) Device
Deadline: 16 Mar 2026
Posting Date: 12 Feb 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 135654821
Document Ref. No.: 2026-102972
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: NOK 3000000
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Development services for minimally invasive glaucoma surgery (MIGS) device We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.
Documents
Tender Notice